Glass Delamination: Holistic approach for characterization and control

Drug stored in glass primary containers risk losing efficacy and safety when not properly tested for corrosion or delamination. These phenomena occur when drug interacts with the inner glass surface over time causing glass matrix dissolution. In 2011, the FDA issued an industry warning leading to aggressive and extensive testing. Learn cases where you can improve product quality and reduce testing with our risk-based approach.